Literature DB >> 15464445

Some like it hot: curcumin and CFTR.

Pamela B Davis1, Mitchell L Drumm.   

Abstract

The activation of mutant forms of the cystic fibrosis transmembrane conductance regulator (CFTR), particularly the most frequent mutant allele (DeltaF508), is a potential strategy for the treatment of the disease cystic fibrosis (CF). Therefore, it is of great interest that curcumin, a component of the spice turmeric, is reported to restore function to this allele, both in heterologous expression systems and in DeltaF508 CF mice. Although other laboratories have not been able to confirm the initial observations, activating DeltaF508 CFTR could have such important therapeutic implications that a thorough investigation of the potential of curcumin is warranted.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464445     DOI: 10.1016/j.molmed.2004.08.001

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  2 in total

1.  SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosis.

Authors:  Barbara R Grubb; Sherif E Gabriel; April Mengos; Martina Gentzsch; Scott H Randell; Anna M Van Heeckeren; Michael R Knowles; Mitchell L Drumm; John R Riordan; Richard C Boucher
Journal:  Am J Respir Cell Mol Biol       Date:  2005-11-11       Impact factor: 6.914

2.  Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy.

Authors:  Savita Bisht; Georg Feldmann; Sheetal Soni; Rajani Ravi; Collins Karikar; Amarnath Maitra; Anirban Maitra
Journal:  J Nanobiotechnology       Date:  2007-04-17       Impact factor: 10.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.